Skip to content

Clinical trials

Phase 3 Heart Failure trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Czechia Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20063
20072
20081
20091
20132
20143
20151
20161
20177
20182
20192
20202
20231
20246
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting12
Terminated5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
AstraZeneca5
Boehringer Ingelheim5
Bayer3
Novo Nordisk A/S3
Amgen2
Colorado Prevention Center2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2
American Regent, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure45
Cardiovascular Diseases4
Myocardial Infarction3
Stroke3
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Heart Diseases2
Hypertension2
Obesity2
Renal Insufficiency, Chronic2

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.